BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36367578)

  • 1. Differentiating high-grade glioma progression from treatment-related changes with dynamic [
    Rozenblum L; Zaragori T; Tran S; Morales-Martinez A; Taillandier L; Blonski M; Rech F; Galanaud D; Kas A; Verger A
    Eur Radiol; 2023 Apr; 33(4):2548-2560. PubMed ID: 36367578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the mechanism of 18F-fluorodopa uptake in recurrent high-grade gliomas: A comprehensive histomolecular-positron emission tomography analysis.
    Cobes N; Tran S; Mathon B; Nichelli L; Bielle F; Touat M; Kas A; Rozenblum L
    Eur J Neurol; 2024 Jan; 31(1):e16093. PubMed ID: 37823694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of dynamic parameters in the analysis of
    Ginet M; Zaragori T; Marie PY; Roch V; Gauchotte G; Rech F; Blonski M; Lamiral Z; Taillandier L; Imbert L; Verger A
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1381-1390. PubMed ID: 31529264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
    Bashir A; Brennum J; Broholm H; Law I
    J Neurosurg; 2018 Apr; 130(2):451-464. PubMed ID: 29624154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and grading accuracy of
    Xiao J; Jin Y; Nie J; Chen F; Ma X
    BMC Cancer; 2019 Aug; 19(1):767. PubMed ID: 31382920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized discrimination of tumor progression from treatment-related changes in different types of adult-type diffuse gliomas using [
    Chen Q; Wang K; Ren X; Zhao X; Chen Q; Fan D; Zhang S; Li X; Ai L
    J Neurooncol; 2023 Dec; 165(3):547-559. PubMed ID: 38095773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identify glioma recurrence and treatment effects with triple-tracer PET/CT.
    Li C; Yi C; Chen Y; Xi S; Guo C; Yang Q; Wang J; Sai K; Zhang J; Ke C; Chen F; Lv Y; Zhang X; Chen Z
    BMC Med Imaging; 2021 May; 21(1):92. PubMed ID: 34059015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential implementation of DSC-MR perfusion and dynamic [
    Steidl E; Langen KJ; Hmeidan SA; Polomac N; Filss CP; Galldiks N; Lohmann P; Keil F; Filipski K; Mottaghy FM; Shah NJ; Steinbach JP; Hattingen E; Maurer GD
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1956-1965. PubMed ID: 33241456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Static
    Song S; Wang L; Yang H; Shan Y; Cheng Y; Xu L; Dong C; Zhao G; Lu J
    Eur Radiol; 2021 Jun; 31(6):4087-4096. PubMed ID: 33211141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[
    Bauer EK; Stoffels G; Blau T; Reifenberger G; Felsberg J; Werner JM; Lohmann P; Rosen J; Ceccon G; Tscherpel C; Rapp M; Sabel M; Filss CP; Shah NJ; Neumaier B; Fink GR; Langen KJ; Galldiks N
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1486-1495. PubMed ID: 32034446
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Patel CB; Fazzari E; Chakhoyan A; Yao J; Raymond C; Nguyen H; Manoukian J; Nguyen N; Pope W; Cloughesy TF; Nghiemphu PL; Czernin J; Lai A; Ellingson BM
    J Neurooncol; 2018 Sep; 139(2):399-409. PubMed ID: 29679199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
    Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W
    J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDH mutation is paradoxically associated with higher
    Verger A; Metellus P; Sala Q; Colin C; Bialecki E; Taieb D; Chinot O; Figarella-Branger D; Guedj E
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1306-1311. PubMed ID: 28293705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TSPO PET signal using [
    Quach S; Holzgreve A; Kaiser L; Unterrainer M; Dekorsy FJ; Nelwan DV; Bartos LM; Kirchleitner SV; Weller J; Weidner L; Niyazi M; Ruf VC; Herms J; Stöcklein S; Wetzel C; Riemenschneider MJ; V Baumgarten L; Thon N; Brendel M; Rupprecht R; Bartenstein P; Tonn JC; Albert NL
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):859-869. PubMed ID: 36329288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic
    Vettermann F; Suchorska B; Unterrainer M; Nelwan D; Forbrig R; Ruf V; Wenter V; Kreth FW; Herms J; Bartenstein P; Tonn JC; Albert NL
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2581-2589. PubMed ID: 31410540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of
    Unterrainer M; Fleischmann DF; Diekmann C; Vomacka L; Lindner S; Vettermann F; Brendel M; Wenter V; Ertl-Wagner B; Herms J; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study.
    Tatekawa H; Yao J; Oughourlian TC; Hagiwara A; Wang C; Raymond C; Lai A; Cloughesy TF; Nghiemphu PL; Liau LM; Salamon N; Ellingson BM
    Clin Nucl Med; 2020 Dec; 45(12):e505-e511. PubMed ID: 33031233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma.
    Karunanithi S; Sharma P; Kumar A; Khangembam BC; Bandopadhyaya GP; Kumar R; Goenka A; Gupta DK; Malhotra A; Bal C
    Eur Radiol; 2013 Sep; 23(9):2628-35. PubMed ID: 23624623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Added value of [
    Darcourt J; Chardin D; Bourg V; Gal J; Schiappa R; Blonski M; Koulibaly PM; Almairac F; Mondot L; Le Jeune F; Collombier L; Kas A; Taillandier L; Verger A
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2727-2735. PubMed ID: 37086272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab.
    Harris RJ; Cloughesy TF; Pope WB; Nghiemphu PL; Lai A; Zaw T; Czernin J; Phelps ME; Chen W; Ellingson BM
    Neuro Oncol; 2012 Aug; 14(8):1079-89. PubMed ID: 22711609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.